The latest information released by the joint panel on multidistrict litigation indicates more than 1,000 patients have now filed a NuvaRing lawsuit over allegations the contraceptive led to blood clot injuries.
Now, after attempts by drug maker Merck to conceal NuvaRing safety studies and several delays in the start of trials, it appears victims may see justice as early as this year.
Judge Rodney Sippel, who is presiding over the cases in a special federal multi-district litigation court in Missouri, has scheduled NuvaRing trials to begin on July 8, 2013. while litigation will begin with several test cases, or “bellweather” trials, these could set the tone for later trials or even a negotiated settlement with Merck.
Experts have linked vaginal rings like NuvaRing to higher risks of blood clots than with traditional birth control pills.
Last May, the British Medical Journal published a Danish study linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. In June, the New England Journal of Medicine also published findings that vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.
This month, researchers at Brigham and Women’s Faulkner Hospital discovered that, while combined hormone vaginal ring contraceptives like NuvaRing can increase blood clot risks for all women, the risks are significantly higher for those suffering migraines.
Blood clots can cause severe or even fatal health conditions like stroke, DVT or pulmonary embolism.
If you or a loved one experienced any of these blood clot injuries after using NuvaRing, it is important to speak with a lawyer about your legal rights as soon as possible. You may be entitled to substantial compensation, however, the time to file a claim is limited.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
Contact us today for more information on the research, side effects and litigation news related to NuvaRing, or to speak with a lawyer.